Top-5 semicap performance in China
- down by 5% to $34.6B in '25- AMAT share down from 47% in 2017 to 24% in 2025- Except for Lam, everyone else declined y/y in '25- ASML went from #5 in 2022 to #1 in 2024- TEL, despite free run in China, declined -17%- KLA first decline since 2018Source: Sravan Kundojjala
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments